Premium
Aclaris Therapeutics Inc (ACRS)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-05 | Dr. Andrew Newman SchiffIndependent Director | 11,58k | 0,00 | Derivative Exercise and Retained Stock | - | 25,54k | 82,95% |
| 2026-06-05 | Mr. Christopher P. MolineauxLead Independent Director | 11,58k | 0,00 | Derivative Exercise and Retained Stock | - | 69,54k | 19,98% |
| 2026-06-05 | Mr. William D. HumphriesIndependent Director | 11,58k | 0,00 | Derivative Exercise and Retained Stock | - | 45,11k | 34,54% |
| 2026-06-05 | Mr. Vincent J. MilanoIndependent Director | 11,58k | 0,00 | Derivative Exercise and Retained Stock | - | 28,90k | 66,87% |
| 2026-06-05 | Dr. Anand MehraIndependent Director | 11,58k | 0,00 | Derivative Exercise and Retained Stock | - | 726,40k | 1,62% |
| 2026-06-05 | Dr. Maxine GowenIndependent Director | 11,58k | 0,00 | Derivative Exercise and Retained Stock | - | 33,33k | 53,23% |
| 2026-05-01 | Dr. Jesse W. HallChief Medical Officer | -9,33k | 41,15k | Derivative Exercise and Sale | 4,41 | 27,05k | - |
| 2026-05-01 | Dr. Jesse W. HallChief Medical Officer | 27,05k | 0,00 | Derivative Exercise and Retained Stock | - | 27,05k | - |
| 2026-04-23 | BML Capital Management, LLCSociété | -300,00k | 1,36M | Vente | 4,53 | 13,95M | -2,11% |
| 2026-03-01 | Mr. Kevin BalthaserCFO | 1,70k | 0,00 | Derivative Exercise and Retained Stock | - | 187,45k | 0,91% |
| 2026-03-01 | Mr. Kevin BalthaserCFO | -677,00 | 1,94k | Derivative Exercise and Sale | 2,87 | 187,45k | - |
| 2026-02-03 | Mr. James LoeropChief Business Officer | 14,94k | 0,00 | Derivative Exercise and Retained Stock | - | 192,26k | 8,42% |
| 2026-02-03 | Mr. James LoeropChief Business Officer | -5,94k | 20,60k | Derivative Exercise and Sale | 3,47 | 192,26k | - |
| 2026-02-03 | Dr. Neal S. WalkerCo-Founder, CEO & Chairman | 44,86k | 0,00 | Derivative Exercise and Retained Stock | - | 1,54M | 2,99% |
| 2026-02-03 | Dr. Neal S. WalkerCo-Founder, CEO & Chairman | -18,61k | 64,58k | Derivative Exercise and Sale | 3,47 | 1,54M | - |
| 2026-02-03 | Dr. Hugh M. DavisPresident, COO & Director | 18,68k | 0,00 | Derivative Exercise and Retained Stock | - | 45,43k | 69,81% |
| 2026-02-03 | Mr. Kevin BalthaserCFO | 15,58k | 0,00 | Derivative Exercise and Retained Stock | - | 185,76k | 9,15% |
| 2026-02-03 | Mr. Kevin BalthaserCFO | -6,45k | 22,38k | Derivative Exercise and Sale | 3,47 | 185,76k | - |
| 2026-02-01 | Mr. James LoeropChief Business Officer | 22,81k | 0,00 | Derivative Exercise and Retained Stock | - | 177,32k | 14,77% |
| 2026-02-01 | Mr. James LoeropChief Business Officer | -10,69k | 37,51k | Derivative Exercise and Sale | 3,51 | 177,32k | - |
| 2026-02-01 | Mr. Kevin BalthaserCFO | 9,77k | 0,00 | Derivative Exercise and Retained Stock | - | 170,18k | 6,09% |
| 2026-02-01 | Mr. Kevin BalthaserCFO | -4,98k | 17,49k | Derivative Exercise and Sale | 3,51 | 170,18k | - |
| 2026-01-02 | Dr. Neal S. WalkerCo-Founder, CEO & Chairman | 19,20k | 0,00 | Derivative Exercise and Retained Stock | - | 1,50M | 1,30% |
| 2026-01-02 | Dr. Neal S. WalkerCo-Founder, CEO & Chairman | -9,95k | 28,66k | Derivative Exercise and Sale | 2,88 | 1,50M | - |
| 2025-12-31 | Mr. James LoeropChief Business Officer | 51,74k | 0,00 | Derivative Exercise and Retained Stock | - | 155,04k | 50,08% |
| 2025-12-31 | Mr. James LoeropChief Business Officer | -40,17k | 120,09k | Derivative Exercise and Sale | 2,88 - 3,01 | 155,04k | - |
| 2025-12-31 | Mr. Kevin BalthaserCFO | 67,81k | 0,00 | Derivative Exercise and Retained Stock | - | 160,41k | 73,22% |
| 2025-12-31 | Mr. Kevin BalthaserCFO | -26,65k | 79,62k | Derivative Exercise and Sale | 2,88 - 3,01 | 160,41k | - |
| 2025-12-02 | Dr. Hugh M. DavisPresident, COO & Director | 26,75k | 0,00 | Derivative Exercise and Retained Stock | - | 26,75k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
